Georgia Bio Blog

Moderna enrolls final volunteers into key coronavirus vaccine study

October 22, 2020

Dive Brief: Moderna has fully enrolled the late-stage study testing its experimental coronavirus vaccine, recruiting 30,000 volunteers from across America in just three months as the company presses forward in an extraordinary push to quickly prove its shot can prevent COVID-19. More than 25,000 of those study participants have now received their second and final dose…

Read More

4 takeaways from FDA’s Covid-19 vaccine meeting

October 22, 2020

While there is no specific vaccine on the table yet, the committee is hearing from federal agencies and vaccine makers about their efforts to prove a shot is both safe and effective. An expert panel advising the Food and Drug Administration on coronavirus vaccines wants more details on who is volunteering for trials and how…

Read More

Covid-19 Vaccines to Be Stored Secretly Under Tight Security

October 21, 2020

Drugmakers and others plan to use fake shipments and GPS trackers to prevent potential thefts Health authorities, hospitals and pharmaceutical companies are storing Covid-19 vaccines in secure, undisclosed locations and taking other steps to protect the shot sagainst a looming threat: theft. As the leading vaccine candidates advance closer to use, vaccine makers such as Pfizer Inc. PFE -1.09% are…

Read More

Pfizer Sets Up Its ‘Biggest Ever’ Vaccination Distribution Campaign

October 21, 2020

In Kalamazoo, Mich., a stretch of land the size of a football field has been turned into a staging ground outfitted with 350 large freezers, ready to take delivery of millions of doses of Covid-19 vaccine before they can be shipped around the world. The facility is a hub in the sprawling supply chain Pfizer Inc. has built…

Read More

Covid-19’s wintry mix: As we move indoors, dry air will help the coronavirus spread

October 21, 2020

It’s not just the cold, it’s the humidity. Winter in the northern United States will soon drive even the most diehard outdoor diners and backyard socializers indoors, bringing with them heightened risk for contracting and spreading Covid-19. The worry is not just that people might mingle more closely inside, but that the air they breathe…

Read More

Ethics arising from EUAs could disrupt COVID-19 vaccine trials

October 20, 2020

FDA and its vaccines advisory committee are facing ethical and practical conundrums that, unless they are resolved quickly, threaten to undermine the development of COVID-19 vaccines. The most pressing challenge centers on whether it is acceptable to continue placebo-controlled, blinded trials after a vaccine has been authorized. If there is a need to unblind trials,…

Read More

‘At a breaking point’: New surge of Covid-19 cases has states, hospitals scrambling, yet again

October 20, 2020

Here we go again. As hospitalizations for Covid-19 inch up around the country, some states are readying plans for field hospitals. Communities are delaying reopening plans and even imposing new measures, though some governors remain opposed to additional restrictions. Deaths — currently standing about 220,000 — have not surged again yet, but that might just…

Read More

Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color

October 20, 2020

When there’s a public health crisis or disaster like the coronavirus pandemic, experts know that the official death tally is going to be an undercount by some extent. Some people who die might never have been tested for the disease, for example, and if people die at home without receiving medical care, they might not…

Read More

Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week – sources

October 20, 2020

CHICAGO/WASHINGTON (Reuters) – AstraZeneca Plc’s AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness in a study participant, four sources told Reuters. AstraZeneca’s large, late-stage U.S. trial has been on hold since Sept. 6, after…

Read More